SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001393905-24-000306
Filing Date
2024-08-29
Accepted
2024-08-29 14:33:02
Documents
7
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT bhsc_6k.htm 6-K 14901
2 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS bhsc_ex991.htm EX-99.1 289492
3 MANAGEMENT’S DISCUSSION AND ANALYSIS bhsc_ex992.htm EX-99.2 110852
4 CERTIFICATE - CEO bhsc_ex993.htm EX-99.3 6573
5 CERTIFICATE - CFO bhsc_ex994.htm EX-99.4 6722
6 IMAGE bhscex992_1.jpg GRAPHIC 10586
7 IMAGE bhscex992_2.jpg GRAPHIC 11580
  Complete submission text file 0001393905-24-000306.txt   460575
Mailing Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6
Business Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6 6046221186
BIOHARVEST SCIENCES INC. (Filer) CIK: 0001723464 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 000-56663 | Film No.: 241262414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)